Cargando…

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients

OBJECTIVE: To identify the gene subtypes related to immune cells of cholangiocarcinoma and construct an immune score model to predict the immunotherapy efficacy and prognosis for cholangiocarcinoma. METHODS: Based on principal component analysis (PCA) algorithm, The Cancer Genome Atlas (TCGA)-cholan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zi-jian, Huang, Yun-peng, Liu, Zhong-tao, Wang, Yong-xiang, Zhou, Hui, Hou, Ke-xiong, Tang, Ji-wang, Xiong, Li, Wen, Yu, Huang, Sheng-fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932535/ https://www.ncbi.nlm.nih.gov/pubmed/36817485 http://dx.doi.org/10.3389/fimmu.2023.1028404

Ejemplares similares

Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma
por: Sae-fung, Apiwit, et al.
Publicado: (2023)

Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis
por: Zhang, Mei-Yin, et al.
Publicado: (2015)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma
por: Zeng, Tian-mei, et al.
Publicado: (2022)

Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature
por: Fu, Denggang, et al.
Publicado: (2021)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy
por: Wang, Zheng, et al.
Publicado: (2022)

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer
por: Wang, Zitao, et al.
Publicado: (2022)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
por: Li, Xinyu, et al.
Publicado: (2020)

Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis
por: Nong, Jiao, et al.
Publicado: (2023)

Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Intersection of nanomaterials and organoids technology in biomedicine
por: Shen, Chen, et al.
Publicado: (2023)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses
por: Huang, Zhen-Dong, et al.
Publicado: (2021)

Proteomic and Metabolomic Signatures Associated With the Immune Response in Healthy Individuals Immunized With an Inactivated SARS-CoV-2 Vaccine
por: Wang, Yi, et al.
Publicado: (2022)

Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis
por: Sun, Bao-Ye, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing
por: Yang, Jia, et al.
Publicado: (2023)

Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study
por: Liu, Jian-Nan, et al.
Publicado: (2020)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Identification of platinum resistance-related gene signature for prognosis and immune analysis in bladder cancer
por: Li, Sheng, et al.
Publicado: (2023)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer
por: Xu, Yan, et al.
Publicado: (2023)

The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer
por: Mak, Tsz Kin, et al.
Publicado: (2022)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
por: Chen, Bangjie, et al.
Publicado: (2022)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
por: Wang, Zhijian, et al.
Publicado: (2023)

Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023)

Bioinformatics Analysis of Inflammation Gene Signature in Indicating Cholangiocarcinoma Prognosis
por: Wang, Yanting, et al.
Publicado: (2022)

Identification of CD4(+) Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer
por: Ning, Shipeng, et al.
Publicado: (2022)

Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer
por: Pan, Zhaoji, et al.
Publicado: (2023)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data
por: Wang, Wanpeng, et al.
Publicado: (2023)

Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis
por: Huang, Guichuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3c5n73h54cds406kpi5c6bg1q5